Alternate-Day Prednisone Therapy

Authors:
  • RMRob Roy MacGregor
    Rob Roy MacGregor
  • JSJohn N. Sheagren
    John N. Sheagren
  • MLMortimer B. Lipsett
    Mortimer B. Lipsett
  • SWSheldon M. Wolff
    Sheldon M. Wolff

Abstract
Patients with a variety of febrile, inflammatory disorders were given an average dose of 62 mg of prednisone every other day for periods lasting from one to 16 months. In seven patients, a switch from daily to alternate-day therapy was followed by increased delayed hypersensitivity responses to appropriate antigens. In five patients started directly on an alternate-day schedule, pre-existing skin reactivity was not suppressed. In addition, six of seven patients could be sensitized to dinitrochlorobenzene while on alternate-day steroids. Patients on the alternate-day schedule had remarkably mild side effects.

This publication has 18 references indexed in Scilit: